Phosphoprotein-based biomarkers as predictors for cancer therapy.

Proceedings of the National Academy of Sciences of the United States of America
Angela M CarterJames A Bibb

Abstract

Disparities in cancer patient responses have prompted widespread searches to identify differences in sensitive vs. nonsensitive populations and form the basis of personalized medicine. This customized approach is dependent upon the development of pathway-specific therapeutics in conjunction with biomarkers that predict patient responses. Here, we show that Cdk5 drives growth in subgroups of patients with multiple types of neuroendocrine neoplasms. Phosphoproteomics and high throughput screening identified phosphorylation sites downstream of Cdk5. These phosphorylation events serve as biomarkers and effectively pinpoint Cdk5-driven tumors. Toward achieving targeted therapy, we demonstrate that mouse models of neuroendocrine cancer are responsive to selective Cdk5 inhibitors and biomimetic nanoparticles are effective vehicles for enhanced tumor targeting and reduction of drug toxicity. Finally, we show that biomarkers of Cdk5-dependent tumors effectively predict response to anti-Cdk5 therapy in patient-derived xenografts. Thus, a phosphoprotein-based diagnostic assay combined with Cdk5-targeted therapy is a rational treatment approach for neuroendocrine malignancies.

References

Jun 1, 1995·Molecular and Cellular Biology·E M HijmansR Bernards
Jul 1, 1993·Human Molecular Genetics·H Donis-KellerS A Wells
Apr 18, 1997·Science·S C ChandrasekharappaS J Marx
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·R Dhavan, L H Tsai
Feb 2, 2002·Nature Reviews. Molecular Cell Biology·Jeffrey M Trimarchi, Jacqueline A Lees
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
May 30, 2003·The Oncologist·Joanna L WeinsteinSusan L Cohn
Feb 3, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Edoardo G GianniniVincenzo Savarino
Jul 8, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·S K AgarwalS J Marx
Oct 21, 2005·Trends in Biochemical Sciences·Marcos Malumbres, Mariano Barbacid
Apr 11, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey I Shapiro
Oct 13, 2006·Journal of Neurochemistry·Marco AngeloK Peter Giese
Dec 6, 2006·The Journal of Biological Chemistry·Ho LinShih-Yi Lin
Jan 10, 2008·Cellular and Molecular Neurobiology·Fatema A Dhariwala, Medha S Rajadhyaksha
May 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ren LiuZixu Mao
Jul 29, 2010·Molecular Cancer Therapeutics·David ParryEmma M Lees
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Razelle KurzrockRavi Salgia
Oct 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A WellsMartin J Schlumberger
Jun 15, 2012·Molecular Biology of the Cell·Abeba DemelashR Ilona Linnoila
Dec 12, 2012·Trends in Biochemical Sciences·Seth M Rubin
Jan 25, 2013·Frontiers in Oncology·Kenichi HirabayashiNaoya Nakamura
Apr 19, 2013·Nature Reviews. Molecular Cell Biology·Frederick A Dick, Seth M Rubin
Jun 21, 2013·PloS One·Hans K GhayeeJerry W Shay
Jul 12, 2013·Nature Reviews. Cancer·Subhashini Sadasivam, James A DeCaprio
Oct 19, 2013·Cancer Cell·Karine PozoJames A Bibb
Feb 20, 2014·International Journal of Biological Sciences·Weiyan XieYazhuo Zhang
Jan 31, 2015·Nature Reviews. Drug Discovery·Uzma AsgharErik S Knudsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

BioRxiv : the Preprint Server for Biology
Angela M CarterJames A Bibb
European Journal of Biochemistry
Ricardo B Maccioni
Nature Immunology
Laurie A Dempsey
© 2021 Meta ULC. All rights reserved